SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.62+0.1%Dec 24 12:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: growthvalue who wrote (24462)8/13/1998 6:02:00 PM
From: Machaon  Read Replies (1) of 32384
 
<< "My guess is that they wanted to effect revenues and earnings ASAP, and ONTAK would do this for them.">>

===> I hope that's not the reason! What's the point of effecting accounting earnings and revenue if it doesn't add value to the company?


Putting aside the argument over whether Seragen adds value, or not....

The market is revenue hungry, at this time. The biotech industry is suffering major harm right now. New biotech IPOs are being shelved due to lack of funding and market interest.

Ligand should understand this. Most biotechs KNOW, in present market conditions, that the sooner they take in bucks, the sooner the market will reward them. (with a few exceptions such as ENMD.)

As an investor in LGND, I appreciate their pipeline, but I am also very interested in Ligand's move to profitability.

Good conversations today on the LGND thread, both Pro and Con. Too bad it's got to end soon.

Regards, Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext